We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Spatial Clustering of Chagas Disease Helps Screening in Peru

By Labmedica staff writers
Posted on 03 Jan 2008
A new targeted-screening strategy could make the diagnosis and treatment of Chagas disease more feasible in low-resource settings. More...
The strategy is based on a study that found that households with infected children were significantly clustered spatially around each other.

Trypanosoma cruzi, the single-cell parasite that causes Chagas disease, is transmitted by triatomine bugs that infest houses in poor communities. The disease, which infects an estimated 11 million people in Latin America, kills more people than any other parasitic disease in the Americas.

Chagas disease control programs have traditionally focused on interrupting the transmission of T. cruzi through vector control measures (such as insecticide spraying), rather than on active case detection and specific treatment of infected people. While control actions have reduced the geographic range and prevalence of major triatomine vectors, without attention to timely diagnosis of those already infected, the window of opportunity for effective treatment (such as giving anti-parasitic drugs) is missed.

A new study has demonstrated an alternative screening strategy that could potentially be much more efficient, cost-effective, and viable in the resource-poor regions plagued by the disease.

Michael Levy of Emory University (Atlanta, GA, USA), the Centers for Disease Control and Prevention, (CDC; Atlanta, GA, USA), currently at the Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA), and colleagues performed a serological survey in children 2-18 years old living in a peri-urban community of Arequipa, Peru, where a vector control campaign is currently disrupting transmission of T. cruzi. They found that 5.3% of children had already been infected by the time their households received insecticide application. They also found that households with infected children were significantly clustered spatially around each other.

The findings were related to data that had been collected during a vector control campaign that included entomological, spatial, and census data. They found that using such data to target diagnostic testing would have identified over 83% of the infected children while testing only 22% of eligible children (only 22% would have to be tested because of the way the households with infected children clustered).

An important reason for the low rates of treatment in Latin America is that health services and control programs lack sufficient resources for comprehensive blood screening and supervised treatment in the most affected areas. Michael Levy's study showed that that data easily collected during an ongoing insecticide spraying campaign in an urban area could be used to identify children at greatest risk of infection with T. cruzi.


Related Links:
Centers for Disease Control and Prevention
Emory University
Fogarty International Center of the National Institutes of Health

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.